{"id":"W2035278640","doi":"10.1016/j.leukres.2014.10.005","title":"Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors","year":2014,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Pfizer","keywords":"Bosutinib; Ponatinib; Nilotinib; Dasatinib; Medicine; Tyrosine kinase; Chronic myelogenous leukemia; Tyrosine-kinase inhibitor; Internal medicine; Imatinib; Pharmacology; Oncology; Leukemia; Myeloid leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.003491497,0.001580492,0.005369623,0.001649889,0.00034913,0.0001043709,0.00106534,0.001395607,0.0003146699],"category_scores_gemma":[0.00077469,0.001100924,0.001452573,0.002310574,0.001035298,0.000230341,0.0004228574,0.002639857,0.0001122612],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.03627658,"about_ca_system_score_gemma":0.02130654,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006584024,"about_ca_topic_score_gemma":0.002502901,"domain_scores_codex":[0.9887324,0.001952921,0.003322067,0.001889193,0.002191979,0.001911416],"domain_scores_gemma":[0.9917842,0.002580109,0.001494378,0.002635148,0.001059129,0.0004470449],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004896398,0.006928454,0.0001044917,0.1351887,0.004287227,0.001188194,0.005276904,0.0003728036,0.02325279,0.0002806067,0.04418049,0.7740429],"study_design_scores_gemma":[0.07064252,0.0203864,0.0002344443,0.05183573,0.004896413,0.0003943476,0.0003128181,0.002536115,0.04235895,0.00003715791,0.8045246,0.00184049],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1323287,0.8519613,0.00003117705,0.0001557644,0.0003218133,0.01363826,0.001289116,0.0000646295,0.0002092911],"genre_scores_gemma":[0.2975844,0.6751514,0.001117074,0.0000901774,0.005692121,0.007360357,0.009967854,0.0005011042,0.002535508],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7722024,"threshold_uncertainty_score":0.9999008,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08836413084802916,"score_gpt":0.4135965523823236,"score_spread":0.3252324215342944,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}